Delivery Order SPE2DB20D2104-SPE2DB25FMFPC
Award Date
1/7/25
Potential Completion Date
1/8/25
Potential Value
$1.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,905.34 firm fixed-price delivery order is for the supply of Myrbetriq ER 50 mg tablets, a medication used to treat overactive bladder. The contract has an ultimate completion date of November 20, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, valued at $11,502.47, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,559,254,026 units of Myrbetriq ER 25 mg tablets, a medication used to treat overactive bladder. This contract is a firm fixed-price delivery order with a completion date of December 5, 2022.
AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $9,743.58, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for the supply of Myrbetriq ER 50 mg tablets, a medication used for the treatment of overactive bladder. The contract has a firm-fixed price pricing type and is set to expire on October 21, 2024.
AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,176.96 firm fixed-price delivery order is for the supply of Myrbetriq ER 25 mg tablets, a medication used to treat overactive bladder. The contract has an ultimate completion date of July 10, 2023.
Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,792.13 firm fixed-price delivery order is for the supply of Myrbetriq ER 50 mg tablets, a medication used to treat overactive bladder. The contract has an ultimate completion date of December 16, 2024.
AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $12,737.42, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Myrbetriq ER 50 MG tablets, a medication used to treat overactive bladder. The award has an ultimate completion date of October 25, 2024 and is structured as a firm fixed-price delivery order. This contract does not have a set-aside designation, indicating...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,002.70 firm fixed-price delivery order is for the supply of Myrbetriq ER 50 mg tablets, a medication used for the treatment of overactive bladder. The award has an ultimate completion date of November 8, 2024 and was made on November 7, 2024. This contract is not designated as a set-aside. Amerisourcebergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,214.78 firm fixed-price delivery order is for the supply of Myrbetriq ER 50 mg tablets, a medication used to treat overactive bladder. The contract has an ultimate completion date of August 8, 2024.
Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,004.38 firm fixed-price delivery order is for the supply of MYRBETRIQ ER 50 MG tablets, a medication used to treat overactive bladder. The contract has an ultimate completion date of November 20, 2024 and was awarded on November 19, 2024. This award is associated with a larger $999,999,999 Indefinite Delivery...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,675.15 firm fixed price delivery order is for the supply of MYRBETRIQ ER 25 MG TABLETS, a medication used for the treatment of overactive bladder. The contract has an ultimate completion date of October 24, 2023.
Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...